TRANSDERMAL DELIVERY OF 5-FLUOROURACIL THROUGH SKIN OF HAIRLESS MICE AND HUMANS INVITRO - A COMPARISON OF THE EFFECT OF FORMULATIONS AND A PRODRUG

被引:15
作者
SHERERTZ, EF
SLOAN, KB
MCTIERNAN, RG
机构
[1] UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT MED CHEM,BOX J-485,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,DEPT MED,GAINESVILLE,FL 32611
[3] VET ADM MED CTR,RES SERV,GAINESVILLE,FL 32602
关键词
5-Fluorouracil (prodrug of 5-FU); Diffusion cell experiment; Isopropyl myristate; Skin; Transdermal delivery;
D O I
10.1007/BF00402624
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A 2% commercial solution formulation of 5-fluorouracil (5-FU) was significantly better at delivering 5-FU than either a 1% or 5% solution. Among single component suspension formulations the highest transdermal delivery was obtained from the vehicle in which 5-FU was least soluble, isopropyl myristate (IPM), while changes in the total suspended concentration of 5-FU in propyleneglycol (PG) had no significant effect on transdermal delivery by those suspensions. A prodrug of 5-FU/IPM was significantly better at delivering 5-FU than any of the formulations. The trends in relative rates of delivery of 5-FU by the formulations and the prodrug were the same in skin of hairless mice and humans. The mouse skin was about ten times more permeable than the human skin. Second application studies to assess skin damage caused by the formulations also showed the same trend in skin of hairless mice and humans: all of the formulations caused some damage. © 1990 Springer-Verlag.
引用
收藏
页码:463 / 468
页数:6
相关论文
共 17 条
[1]   PENETRATION OF 5-FLUOROURACIL IN EXCISED SKIN [J].
COHEN, JL ;
STOUGHTON, RB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1974, 62 (05) :507-509
[2]   FURTHER STUDIES WITH TOPICAL 5-FLUOROURACIL [J].
DILLAHA, CJ ;
JANSEN, GT ;
HONEYCUTT, WM ;
HOLT, GA .
ARCHIVES OF DERMATOLOGY, 1965, 92 (04) :410-+
[3]   SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL [J].
DILLAHA, CJ ;
HONEYCUTT, WM ;
BRADFORD, AC ;
JANSEN, GT .
ARCHIVES OF DERMATOLOGY, 1963, 88 (03) :247-+
[4]  
FLYNN GL, 1972, J PHARM SCI, V61, P61
[5]   TOPICAL CHEMOTHERAPY WITH 5-FLUOROURACIL - A REVIEW [J].
GOETTE, DK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 4 (06) :633-649
[6]  
HADGRAFT J, 1968, INT J PHARM, V32, P257
[7]  
Higuchi T, 1960, J SOC COSMET CHEM, V11, P85
[8]   PHYSICOCHEMICAL STUDY OF PERCUTANEOUS-ABSORPTION ENHANCEMENT BY DIMETHYLSULFOXIDE - DIMETHYLSULFOXIDE MEDIATION OF VIDARABINE (ARA-A) PERMEATION OF HAIRLESS MOUSE SKIN [J].
KURIHARABERGSTROM, T ;
FLYNN, GL ;
HIGUCHI, WI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (03) :274-280
[9]   INFLUENCE OF DRUG SOLUBILITY IN THE VEHICLE ON CLINICAL EFFICACY OF OINTMENTS [J].
MALZFELDT, E ;
LEHMANN, P ;
GOERZ, G ;
LIPPOLD, BC .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1989, 281 (03) :193-197
[10]  
MOLLGAARD B, 1983, ACTA PHARM SUEC, V20, P443